Synaptive Medical Denmark ApS: Financial statements 2019
CVR: 38607154
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Synaptive Medical Denmark ApS (CVR 38607154) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -11,888 and a net result of DKK -15,335 compared with DKK 44,602 the year before. Equity in the 2019 report amounted to DKK 146,972. The solvency ratio was 30.7%.
- Gross Profit
- DKK -11,888
- Profit/Loss
- DKK -15,335
- Equity
- DKK 146,972
- Total Assets
- DKK 479,232
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Synaptive Medical Denmark ApS has published its annual report for 2018. Gross profit came to DKK 58,567, and the net result was DKK 44,602.
As of March 6, 2019, Peter Lee Wehrly has joined the board of directors of Synaptive Medical Denmark ApS.
As of March 6, 2019, George Peter Dans has left the board of directors of Synaptive Medical Denmark ApS.
As of January 17, 2019, Peter Lee Wehrly is registered as director of Synaptive Medical Denmark ApS.
As of January 17, 2019, George Peter Dans has stepped down as director of Synaptive Medical Denmark ApS.
About Synaptive Medical Denmark ApS
Synaptive Medical Denmark ApS was a Danish company of the type Anpartsselskab based in København K, founded in 2017. The company has been dissolved on 18 May 2026. The company was registered under the industry Engroshandel med læge- og hospitalsartikler. According to the 2021 annual report, the company had an average of 0 employees. In 2021, the company reported a gross profit of DKK 0 and a net result of DKK -2,637 compared with DKK -130,149 the year before. Equity in the 2021 report amounted to DKK 14,186.